VTR Earnings Date: Feb 4, 2027 (Estimated) — Ventas, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities
Updated
When is VTR's next earnings date?
Ventas, Inc. (VTR) is expected to report Q4 2026 earnings on Thursday, February 4, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.00 on revenue of $1.80B.
How did VTR do in its last earnings report?
In its most recent report on Oct 27, 2026 (Q3 2026), Ventas, Inc. posted EPS of $0.13 versus the $0.16 estimate, a miss of 19.8%. Revenue was $1.83B against a $1.77B estimate. The stock's 1-day post-earnings move was -2.7%.
How much does VTR stock move after earnings?
VTR beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.7% (up or down) in the day after earnings.
About Ventas, Inc.
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
🤖 AI Earnings Analysis
Ventas delivered a mixed quarter: healthcare-property revenue rose to $1.8B from $1.5B, but EPS of $0.13 missed estimates by $0.03. Its $3.85–$3.90 EPS outlook offers support, though earnings quality warrants scrutiny.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | Q3 2026 | 0.16 | 0.13 | -19.80% | $1.83B | ❌ Miss | -2.72% | — | — |
| 2026-07-29 | Q2 2026 | 0.96 | 0.97 | +1.04% | $1.73B | ✅ Beat | -5.94% | -5.31% | -4.95% |
| 2026-04-27 | Q1 2026 | 0.91 | 0.94 | +3.30% | $1.66B | ✅ Beat | +3.39% | +3.66% | +3.95% |
| 2026-02-05 | Q4 2025 | 0.41 | 0.89 | +117.07% | $1.57B | ✅ Beat | +3.39% | +6.71% | +7.97% |
| 2025-10-29 | Q3 2025 | 0.38 | 0.88 | +131.58% | $1.49B | ✅ Beat | +6.56% | +7.46% | +15.55% |
| 2025-07-30 | Q2 2025 | 0.34 | 0.87 | +155.88% | $1.42B | ✅ Beat | +1.06% | +3.04% | +1.60% |
| 2025-04-30 | Q1 2025 | 0.82 | 0.84 | +2.44% | $1.36B | ✅ Beat | -6.47% | -5.71% | -8.28% |
| 2025-02-12 | Q4 2024 | 0.80 | 0.81 | +1.25% | $1.29B | ✅ Beat | +8.33% | +11.53% | +11.58% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $1.81B total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Senior Living Operations | 80.0% | $1.45B | +33.3% | $968.9M | $1.03B | $1.09B | $1.19B |
| Outpatient Medical And Research Portfolio | 12.9% | $234.0M | +3.1% | — | $221.5M | $226.9M | $449.5M |
| Triple Net Leased Properties | 7.1% | $129.5M | -19.1% | $156.1M | $152.7M | $160.1M | $132.7M |
By region
Q1 FY24 · $1.20B total
| Segment | Share | Revenue | YoY | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 88.6% | $1.06B | +11.0% | $918.1M | $933.2M | $958.1M | $983.7M |
| CANADA | 10.7% | $129.0M | +15.0% | $112.5M | $111.6M | $112.1M | $115.3M |
| UNITED KINGDOM | 0.6% | $7.6M | +8.2% | $6.6M | $6.6M | $7.0M | $7.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.